Krystal Biotech Inc. (KRYS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Krystal Biotech Inc.

    NASDAQ: KRYS · Real-Time Price · USD
    167.82
    6.67 (4.14%)
    At close: Sep 26, 2025, 3:59 PM
    167.82
    0.00%
    After-hours: Sep 26, 2025, 05:18 PM EDT

    Krystal Biotech Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 344.87M 358.33M 161.9M 341.25M
    Short-Term Investments
    		 252.65M 173.85M 217.27M 96.85M
    Long-Term Investments
    		 152.11M 61.95M 4.62M 64.37M
    Other Long-Term Assets
    		 231K 263K 324K 74K
    Receivables
    		 104.75M 42.04M n/a n/a
    Inventory
    		 26.51M 6.99M n/a n/a
    Other Current Assets
    		 13.27M 6.71M 4.61M 4.17M
    Total Current Assets
    		 742.04M 587.91M 383.78M 442.27M
    Property-Plant & Equipment
    		 161.45M 168.23M 169.73M 119.58M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 313.79M 230.45M 174.67M 184.03M
    Total Assets
    		 1.06B 818.36M 558.45M 626.29M
    Account Payables
    		 4.99M 1.85M 3.98M 8.4M
    Deferred Revenue
    		 n/a n/a n/a 16.21M
    Short-Term Debt
    		 n/a n/a 1.56M n/a
    Other Current Liabilities
    		 2.4M 16.75M 14.92M 13.41M
    Total Current Liabilities
    		 102M 33.09M 28.85M 25.74M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 1.42M n/a n/a n/a
    Total Long-Term Liabilities
    		 7.46M 6.62M 7.37M 6.98M
    Total Liabilities
    		 109.46M 39.71M 36.22M 32.72M
    Total Debt
    		 7.26M 8.09M 8.93M 8.02M
    Book Value
    		 946.38M 778.64M 522.23M 593.58M
    Book Value Per Share
    		 33.10 28.67 20.49 26.74
    Common Stock
    		 n/a n/a n/a n/a
    Retained Earnings
    		 -180.67M -269.83M -280.76M -140.78M
    Comprehensive Income
    		 -190K 638K -728K -163K
    Shareholders Equity
    		 946.38M 778.64M 522.23M 593.58M
    Total Investments
    		 404.77M 235.8M 221.89M 161.22M

    Add to Watchlist